SXL
AMGN icon

Summit X LLC’s Amgen AMGN Stock Holding History

Summit X LLC’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-824
Closed -$230K – 9
2025
Q2 		$230K Sell
824
-536
-39% -$152K 0.04% 232
2025
Q1 		$424K Sell
1,360
-385
-22% -$114K 0.09% 138
2024
Q4 		$455K Buy
+1,745
New +$518K 0.1% 128
2024
Q3 		– Sell
-794
Closed -$255K – 214
2024
Q2 		$255K Buy
+794
New +$233K 0.06% 205

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Summit X LLC's AMGN Position: Q3 2025 in Review

Summit X LLC sold out of Amgen (AMGN) in Q3 2025, closing a stake of 824 shares — an estimated $230K sold.

Summit X LLC first reported a position in AMGN in Q2 2024 and held it in 4 quarters. The position peaked at $455K in Q4 2024. 2,826 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Summit X LLC reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Summit X LLC sold 824 Amgen shares in Q3 2025, an estimated $230K.
  • Summit X LLC first reported a position in Amgen in Q2 2024 and held it in 4 quarters.
  • Summit X LLC's Amgen position peaked at $455K in Q4 2024.
  • 2,826 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.